Logo image of CNVS

CINEVERSE CORP (CNVS) Stock Fundamental Analysis

USA - NASDAQ:CNVS - US1724063086 - Common Stock

3.38 USD
-0.12 (-3.43%)
Last: 9/25/2025, 7:13:05 PM
3.58 USD
+0.2 (+5.92%)
After Hours: 9/25/2025, 7:13:05 PM
Fundamental Rating

4

Taking everything into account, CNVS scores 4 out of 10 in our fundamental rating. CNVS was compared to 80 industry peers in the Entertainment industry. Both the profitability and the financial health of CNVS get a neutral evaluation. Nothing too spectacular is happening here. CNVS is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CNVS was profitable.
CNVS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CNVS reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: CNVS reported negative operating cash flow in multiple years.
CNVS Yearly Net Income VS EBIT VS OCF VS FCFCNVS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M -40M -60M

1.2 Ratios

CNVS has a better Return On Assets (4.49%) than 80.00% of its industry peers.
With a decent Return On Equity value of 7.45%, CNVS is doing good in the industry, outperforming 76.25% of the companies in the same industry.
CNVS has a better Return On Invested Capital (13.82%) than 91.25% of its industry peers.
Industry RankSector Rank
ROA 4.49%
ROE 7.45%
ROIC 13.82%
ROA(3y)-13.6%
ROA(5y)-24.58%
ROE(3y)-27.36%
ROE(5y)-89.05%
ROIC(3y)N/A
ROIC(5y)N/A
CNVS Yearly ROA, ROE, ROICCNVS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200 -300

1.3 Margins

CNVS has a better Profit Margin (3.44%) than 68.75% of its industry peers.
In the last couple of years the Profit Margin of CNVS has grown nicely.
With a decent Operating Margin value of 8.73%, CNVS is doing good in the industry, outperforming 71.25% of the companies in the same industry.
In the last couple of years the Operating Margin of CNVS has grown nicely.
CNVS has a Gross Margin (51.23%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CNVS has declined.
Industry RankSector Rank
OM 8.73%
PM (TTM) 3.44%
GM 51.23%
OM growth 3Y72.9%
OM growth 5YN/A
PM growth 3Y8.97%
PM growth 5YN/A
GM growth 3Y-7.04%
GM growth 5Y-2.17%
CNVS Yearly Profit, Operating, Gross MarginsCNVS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150 -200

4

2. Health

2.1 Basic Checks

CNVS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CNVS has more shares outstanding
The number of shares outstanding for CNVS has been increased compared to 5 years ago.
CNVS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CNVS Yearly Shares OutstandingCNVS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
CNVS Yearly Total Debt VS Total AssetsCNVS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of -8.17, we must say that CNVS is in the distress zone and has some risk of bankruptcy.
CNVS's Altman-Z score of -8.17 is on the low side compared to the rest of the industry. CNVS is outperformed by 81.25% of its industry peers.
The Debt to FCF ratio of CNVS is 0.90, which is an excellent value as it means it would take CNVS, only 0.90 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.90, CNVS belongs to the best of the industry, outperforming 83.75% of the companies in the same industry.
CNVS has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CNVS (0.10) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 0.9
Altman-Z -8.17
ROIC/WACC1.45
WACC9.55%
CNVS Yearly LT Debt VS Equity VS FCFCNVS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 0.99 indicates that CNVS may have some problems paying its short term obligations.
CNVS's Current ratio of 0.99 is in line compared to the rest of the industry. CNVS outperforms 47.50% of its industry peers.
CNVS has a Quick Ratio of 0.99. This is a bad value and indicates that CNVS is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.99, CNVS perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.99
CNVS Yearly Current Assets VS Current LiabilitesCNVS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 115.38% over the past year.
CNVS shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.06% yearly.
CNVS shows a strong growth in Revenue. In the last year, the Revenue has grown by 77.08%.
Measured over the past years, CNVS shows a quite strong growth in Revenue. The Revenue has been growing by 14.75% on average per year.
EPS 1Y (TTM)115.38%
EPS 3Y-3.06%
EPS 5YN/A
EPS Q2Q%-5%
Revenue 1Y (TTM)77.08%
Revenue growth 3Y11.7%
Revenue growth 5Y14.75%
Sales Q2Q%21.83%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y47.33%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.46%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CNVS Yearly Revenue VS EstimatesCNVS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
CNVS Yearly EPS VS EstimatesCNVS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2019 2021 2022 2023 2024 2025 2026 0 -20 -40 -60 -80 -100

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 42.25 indicates a quite expensive valuation of CNVS.
Based on the Price/Earnings ratio, CNVS is valued a bit cheaper than the industry average as 76.25% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.06, CNVS is valued quite expensively.
The Price/Forward Earnings ratio is 25.49, which means the current valuation is very expensive for CNVS.
Based on the Price/Forward Earnings ratio, CNVS is valued a bit cheaper than 72.50% of the companies in the same industry.
CNVS is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.64, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 42.25
Fwd PE 25.49
CNVS Price Earnings VS Forward Price EarningsCNVS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

88.75% of the companies in the same industry are more expensive than CNVS, based on the Enterprise Value to EBITDA ratio.
88.75% of the companies in the same industry are more expensive than CNVS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 15.97
EV/EBITDA 5.89
CNVS Per share dataCNVS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.89
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CNVS!.
Industry RankSector Rank
Dividend Yield N/A

CINEVERSE CORP

NASDAQ:CNVS (9/25/2025, 7:13:05 PM)

After market: 3.58 +0.2 (+5.92%)

3.38

-0.12 (-3.43%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-14 2025-08-14/amc
Earnings (Next)11-12 2025-11-12
Inst Owners15.81%
Inst Owner Change33.84%
Ins Owners13.53%
Ins Owner Change1.88%
Market Cap64.49M
Analysts82.5
Price Target8.67 (156.51%)
Short Float %3.5%
Short Ratio1.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.53%
Min EPS beat(2)-157.35%
Max EPS beat(2)152.29%
EPS beat(4)3
Avg EPS beat(4)7.67%
Min EPS beat(4)-157.35%
Max EPS beat(4)152.29%
EPS beat(8)5
Avg EPS beat(8)11.57%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)7.03%
Min Revenue beat(2)6.87%
Max Revenue beat(2)7.19%
Revenue beat(4)4
Avg Revenue beat(4)10.02%
Min Revenue beat(4)6.87%
Max Revenue beat(4)16.23%
Revenue beat(8)4
Avg Revenue beat(8)-0.53%
Revenue beat(12)6
Avg Revenue beat(12)3%
Revenue beat(16)9
Avg Revenue beat(16)6.79%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-550%
EPS NQ rev (3m)-800%
EPS NY rev (1m)0%
EPS NY rev (3m)244.44%
Revenue NQ rev (1m)9.91%
Revenue NQ rev (3m)-0.39%
Revenue NY rev (1m)-0.52%
Revenue NY rev (3m)3.31%
Valuation
Industry RankSector Rank
PE 42.25
Fwd PE 25.49
P/S 0.8
P/FCF 15.97
P/OCF 14.02
P/B 1.74
P/tB 5.46
EV/EBITDA 5.89
EPS(TTM)0.08
EY2.37%
EPS(NY)0.13
Fwd EY3.92%
FCF(TTM)0.21
FCFY6.26%
OCF(TTM)0.24
OCFY7.13%
SpS4.2
BVpS1.94
TBVpS0.62
PEG (NY)0.89
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.49%
ROE 7.45%
ROCE 19.23%
ROIC 13.82%
ROICexc 14.54%
ROICexgc 43.24%
OM 8.73%
PM (TTM) 3.44%
GM 51.23%
FCFM 5.04%
ROA(3y)-13.6%
ROA(5y)-24.58%
ROE(3y)-27.36%
ROE(5y)-89.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y117.54%
ROICexc growth 5YN/A
OM growth 3Y72.9%
OM growth 5YN/A
PM growth 3Y8.97%
PM growth 5YN/A
GM growth 3Y-7.04%
GM growth 5Y-2.17%
F-Score7
Asset Turnover1.3
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 0.9
Debt/EBITDA 0.33
Cap/Depr 14.09%
Cap/Sales 0.7%
Interest Coverage 8.81
Cash Conversion 41.84%
Profit Quality 146.3%
Current Ratio 0.99
Quick Ratio 0.99
Altman-Z -8.17
F-Score7
WACC9.55%
ROIC/WACC1.45
Cap/Depr(3y)30.78%
Cap/Depr(5y)28.81%
Cap/Sales(3y)1.85%
Cap/Sales(5y)3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)115.38%
EPS 3Y-3.06%
EPS 5YN/A
EPS Q2Q%-5%
EPS Next Y47.33%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)77.08%
Revenue growth 3Y11.7%
Revenue growth 5Y14.75%
Sales Q2Q%21.83%
Revenue Next Year0.46%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y504.16%
EBIT growth 3Y93.13%
EBIT growth 5YN/A
EBIT Next Year94.27%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y132.94%
FCF growth 3Y56.46%
FCF growth 5Y20.06%
OCF growth 1Y142.37%
OCF growth 3Y52.8%
OCF growth 5Y17.54%